7,654.75

+40.75

+0.54%

52,223.00

+305.00

+0.59%

28,776.25

+242.25

+0.85%

Russell 2000 Futures

2,843.40

+22.10

+0.78%

4.9290

-0.0600

-1.20%

19.05

-0.37

-1.91%

3,915.00

+16.10

+0.41%

77,778.07

-52.00

-0.07%

Crude Oil Dec 26

99.26

-4.86

-4.67%

US Private Equity

10,850.63

-82.20

-0.75%

OTC Markets OTCQX - Delayed Quote USD

Cannara Biotech Inc. (LOVFF)

1.4280 0.0000 (0.00%)

At close: October 30 at 5:00:00 PM EDT

Loading Chart for LOVFF

Chart Range Bar

Interval:

In partnership with ChartIQ

Cannara Expands International Supply Agreement with Curaleaf

Cannara Expands International Supply Agreement with Curaleaf

Cannara Expands Financing to an $80 Million Syndicated Credit Facility with BMO and TD Bank, Further Strengthening Its Financial Foundation for Continued Growth

Cannara Expands Financing to an $80 Million Syndicated Credit Facility with BMO and TD Bank, Further Strengthening Its Financial Foundation for Continued Growth

Cannara Appoints Nicholas Fozard as Chief Financial Officer

Cannara Appoints Nicholas Fozard as Chief Financial Officer

Cannara Establishes Automatic Share Purchase Plan

Cannara Establishes Automatic Share Purchase Plan

Cannara Announces Normal Course Issuer Bid

Cannara Announces Normal Course Issuer Bid

Cannara Reports Record Q3 Revenues and Continued Profitability Accompanied By Expanding National Distribution and Accelerated Capacity Expansion

Cannara Reports Record Q3 Revenues and Continued Profitability Accompanied By Expanding National Distribution and Accelerated Capacity Expansion

Cannara Announces a Long-Term International Cannabis Supply Agreement with Curaleaf International Limited

Cannara Announces a Long-Term International Cannabis Supply Agreement with Curaleaf International Limited

Cannara to Announce Fiscal Q3 2026 Financial Results on July 15, 2026

Cannara to Announce Fiscal Q3 2026 Financial Results on July 15, 2026

Cannara Secures Exclusive Canadian Rights to Blue River's Ampersand™ Live Rosin Infusion Technology

Cannara Secures Exclusive Canadian Rights to Blue River's Ampersand™ Live Rosin Infusion Technology

Cannara Completes Acquisition of Medican Organic Inc.

Cannara Completes Acquisition of Medican Organic Inc.

Cannara Reports Q2 Fiscal 2026 Results with Continued Profitability, Strong Operating Cash Flow and #1 Retail Market Share in Québec

Cannara Reports Q2 Fiscal 2026 Results with Continued Profitability, Strong Operating Cash Flow and #1 Retail Market Share in Québec

Mobilize your Website

View Site in Mobile | Classic

Share by: